Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Andrew M. Roecker"'
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 4 (2010)
Nelarabine is a nucleoside analog indicated for the treatment of adult and pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL) that is refractory or has relapsed after treatment with at least t
Externí odkaz:
https://doaj.org/article/03f14c3373e842ddb515f3ed61e6e198
Publikováno v:
The Annals of pharmacotherapy. 50(8)
Objective: Summarize data on the pathophysiology, treatment, and prevention options for non–AIDS immunocompromised patients who have Pneumocystis jirovecii pneumonia (PJP); review the epidemiology of patients presenting with PJP; and discuss the fi
Publikováno v:
Future Oncology. 2:441-448
Nelarabine is a nucleoside analog prodrug of 9-β-D-arabinofuranosylguanine. Nelarabine is indicated for the treatment of adult and pediatric patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma whose disease has not res
Autor:
Scott D Pope, Andrew M. Roecker
Publikováno v:
Expert opinion on pharmacotherapy. 9(10)
Dalbavancin is a lipoglycopeptide antibacterial agent with in vitro and in vivo activity against a number of Gram-positive organisms, including some with multidrug resistance. This is a review of the available literature explaining the pertinent info
Publikováno v:
American Journal of Health-System Pharmacy. 12/15/2004, Vol. 61 Issue 24, p2684. 3p.
Publikováno v:
Annals of Pharmacotherapy; Aug2016, Vol. 50 Issue 8, p673-679, 7p
Publikováno v:
Future Oncology; Aug2006, Vol. 2 Issue 4, p441-448, 8p
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. 25+ additional chapters available online! The classic guide t
Autor:
Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
The most comprehensive text available on the use of evidence-based medication therapies for optimal patient outcomes – updated with the latest breakthroughs and guidelines A Doody's Core Title for 2019! Pharmacotherapy: A Pathophysiologic Approach